慢性乙型肝炎患者血清IL-17、IL-6水平研究

Detection of the serum level of interleukin-17 in the chronic hepatitis B patients

目的 探讨慢性乙型肝炎患者血清白细胞介素-17（IL-17）水平变化及其在慢性肝炎肝损伤中的意义.方法 采用ELISA方法检测42例慢性轻度乙肝患者、37例慢性中度乙肝患者、38例慢性重度乙肝患者及50例正常对者血清IL-17浓度,采用放射免疫方法测定血清IL-6、IL-8浓度.结果 IL-17、IL-6、IL-8水平在各组乙肝患者血清中均高于正常对照组,差异有统计学意义（P〈0.01）,慢性轻度乙肝患者与中度患者相比,差异无统计学意义,慢性重度患者与轻、中度患者相比明显升高,差异有统计学意义（P〈0.01）.结论 IL-17可能在慢性乙型肝炎的疾病过程中扮演着免疫与炎症的双重角色,作为一种新近发现的细胞因子,它可能在临床上对乙肝患者的治疗提供一种新的思路.

Objective To research serum level of interleukin-17 （IL-17）associated with the progression of hepatic injury in the chronic patients with hepatitis B. Methods The serum level of IL-17 was measured by ELISA and the serum levels of IL-6,IL-8 were measured by RIA in patient groups and healthy group, the patient groups including 42 mild patients, 37 moderate patients and 38 severe patients. Results IL-17,IL-6 and IL-8 levels in patient patients were significantly higher than those in healthy people（P〈 0.01）. There is no significant difference among mild patients and moderate patients. Compared with mild patients and moderate patients, the cytokines lever were significantly higher in severe patients（P〈0.01）. Conclusion IL-17 as a new cytokine probably play a multiple role as immune factor and inflammation element in the progression of the chronic hepatitis B disease. Maybe, it can provide a new approach to the therapy of the chronic hepatitis B.